Jury Awards $16 Million in Mistaken Cancer Case
- Share via
A Seattle jury awarded $16.2 million to a woman who underwent chemotherapy, a hysterectomy and partial lung removal after being diagnosed with cancer she never had, her lawyer said.
The jury called for $8.1 million each from drug and health care products maker Abbott Laboratories Inc. and the University of Washington Medical Center.
Illinois-based Abbott said it would appeal, saying doctors misused its test kits, which falsely indicated a rare, lethal form of cancer.
In a statement, the University of Washington said it acted properly to treat what it thought was a life-threatening illness and blamed Abbott for failing to warn that its kits could give false positive readings.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
